Successors Clause Example from Business Contracts

This example Successors clause appears in 19 contracts from 10 companies

Successors. This Underwriting Agreement will inure to the benefit of and be binding upon the parties hereto and their respective successors and the officers, directors, employees, agents and controlling persons referred to in Section 8 hereof, and no other person will have any right or obligation hereunder.
Found in Kadmon Holdings, Inc. contract
PhaseBio Pharmaceuticals Inc Contracts

Form of Underwriting Agreement (Filed With SEC on April 9, 2019)

Form of Underwriting Agreement (Filed With SEC on October 5, 2018)

EYENOVIA, INC. Contracts

Underwriting Agreement, dated July 11, 2019, by and among Eyenovia, Inc. and Oppenheimer & Co. Inc., as representative of the several underwriters named therein (Filed With SEC on July 15, 2019)

Underwriting Agreement, dated August 19, 2020, by and between Eyenovia, Inc. and William Blair & Company, L.L.C. as representative of the several underwriters named therein (Filed With SEC on August 21, 2020)

Form of Underwriting Agreement (Filed With SEC on January 9, 2018)

CRISPR Therapeutics AG Contracts

Underwriting Agreement, dated as of November 20, 2019, among CRISPR Therapeutics AG and Goldman Sachs & Co. LLC, Piper Jaffray & Co. and Jefferies LLC, as representatives of the... (Filed With SEC on November 22, 2019)

Underwriting Agreement, dated as of June 30, 2020, among CRISPR Therapeutics AG and Goldman Sachs & Co. LLC, BofA Securities, Inc. and Jefferies LLC, as representatives of the... (Filed With SEC on July 2, 2020)

Underwriting Agreement, dated as of September 20, 2018, among CRISPR Therapeutics AG and Goldman Sachs & Co. LLC, Piper Jaffray & Co. and Barclays Capital Inc. as representatives... (Filed With SEC on September 21, 2018)

Underwriting Agreement, dated as of January 4, 2018, among CRISPR Therapeutics AG and Goldman Sachs & Co. LLC, Piper Jaffray & Co. and Barclays Capital Inc., as representatives of... (Filed With SEC on January 5, 2018)

CRISPR THERAPEUTICS AG Common Shares (nominal value CHF 0.03 per share) Underwriting Agreement (Filed With SEC on October 7, 2016)

Immunome Inc. Contracts

Form of Underwriting Agreement (Filed With SEC on September 9, 2020)

FEMASYS INC Contracts

Form of Underwriting Agreement (Filed With SEC on June 14, 2021)

ALZHEON, INC. Contracts

Form of Underwriting Agreement (Filed With SEC on September 28, 2018)

Form of Underwriting Agreement (Filed With SEC on March 16, 2018)

Kadmon Holdings, Inc. Contracts

Underwriting Agreement, dated June 11, 2018, by and among the Company and Jefferies LLC, as representative of the underwriters listed therein (Filed With SEC on June 14, 2018)

Underwriting Agreement, dated September 26, 2017, by and among the Company and Jefferies LLC and Piper Jaffray & Co., as representatives of the several underwriters listed therein (Filed With SEC on September 28, 2017)

Myovant Sciences Ltd. Contracts

Myovant Sciences Ltd. [] Shares 1 Common Shares ($0.00001 parvalue) Underwriting Agreement (Filed With SEC on October 17, 2016)

Arsanis, Inc. Contracts

Arsanis, Inc. [] Shares Common Stock ($0.001 parvalue) Underwriting Agreement (Filed With SEC on November 6, 2017)

Krystal Biotech, Inc. Contracts

Form of Underwriting Agreement (Filed With SEC on September 14, 2017)